arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

IRADIMED CORP

IRMD
$85.33 ▼ -3.28 (-3.70%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
56 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
82
Health
Excellent
Bullish
auto_awesome

Analytical Summary

IRADIMED CORP shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.1B
Dividend Yield —
Revenue Growth 14.2% ↗
Op. Margin 33.6% ↗
ROIC 5.7% ↗
FCF / Share $0.54 ↗
Trailing P/E 167.3x
Price / Book 10.3x
FCF Yield 0.6%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

56-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$24.20M
↑ +14.2% —
Net Income Profit after all expenses
$5.82M
↑ +24.1% —
Operating Margin Operating profit as % of sales
33.6%
↑ +7.7% 87th
FCF / Share Free cash flow per share
$0.54
↑ +19.3% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
86
Returns ↑
89
Cash Quality ↓
52

Dividend History

Dividend / share · sourced from SEC filings
$0.48 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 56 quarters